Maropitant citrateProduct ingredient for Maropitant
- Name
- Maropitant citrate
- Drug Entry
- Maropitant
Maropitant, used as maropitant citrate, is a neurokinin receptor antagonist, which was developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007 for use in dogs, and more recently has also been approved for use in cats.
- Accession Number
- DBSALT001715
- Structure
Structure for Maropitant citrate (DBSALT001715)
- Synonyms
- Maropitant citrate monohydrate
- External IDs
- CJ-11,972 / CJ-11972